Welcome to Rhineland-Palatinate and Mainz – 
a hub for biotechnology and life sciences!

Benefits and prospects for the region:

  • > 500

    research projects with a biotech focus are currently underway across the state.

  • 13,6

    patents per million inhabitants, making Rhineland-Palatinate Germany's foremost centre of scientific innovation.

  • TOP 3

    worldwide: Mainz is ranked among the top global locations in the field of mRNA-based vaccines.

  • > 55 k

    employs the biotechnology sector in Rhineland-Palatinate – and rising.

A new promotional video by the state and the city of Mainz focuses on these and other aspects while highlighting the benefits and prospects the region offers companies, start-ups and people involved in scientific research. 

Today, the German state of Rhineland-Palatinate and its capital, Mainz, have established themselves as a leading hub for research, science and business that boasts a wealth of expertise. This is where fundamental research makes the transition into real-world applications. 

Alongside a number of leading global players and centres of scientific excellence as well as a high level of AI proficiency, there is also a thriving start-up ecosystem throughout the state that is constantly working to shape a better future with creativity and an enterprising mindset.